Peptide Powder Melanotan-2 Melanotan II

Melanotan II nécessite une dose cumulative pour être efficace. En fonction de l'individu, la dose cumulée nécessaire sera généralement de 10 à 40 mg, les individus plus justes exigeant généralement des montants situés à l’extrémité supérieure de la fourchette. En fonction de la quantité totale nécessaire et de la posologie quotidienne adaptée à l'individu, Les injections de MT-II devront commencer au moins une semaine avant de devoir améliorer le bronzage.. Plus généralement, MT-II use should begin at least a month prior to such need.Melanotan II can also be used on a cycled basis to maintain improved ability to tan.Further, Melanotan II peut être utilisé occasionnellement pour un effet prosexuel.

Mélanotan-1, the precusor to Melanotan II, would eventually be licensed for commercialization as a tanning agent and has been in development for use as a potential “therapeutic tan,” with minimal need for prolonged sun exposure. In the initial clinical testing of Melanotan II, an immediate and unexpected response was noted. The main subject experienced an erection shortly after administration. It was suggested that Melanotan II “may prove equally effective in women” as a “treatment of female sexual dysfunction. At least one study has observed that administration of Melanotan II may increase sexual desire, which should warrant further “investigation of centrally acting agents on disorders of sexual desire.
Theoretically, Melanotan II may enhance sexual function in males (erectile activity) and females (increased levels of sexual desire and genital arousal). Unlike other sexual-enhancement drugs, it is hypothesizedd that Melanotan II works at a neurological level, eliciting a more “natural” sexual response with minimal side effects. It was suggested that Melanotan II “may prove equally effective in women” as a “treatment of female sexual dysfunction.[5] At least one study has observed that administration of Melanotan II may increase sexual desire, which should warrant further “investigation of centrally acting agents on disorders of sexual desire.